Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
Author Information
Author(s): Saito Fumiaki, Matsumura Kiichiro
Primary Institution: Teikyo University School of Medicine
Hypothesis
The study investigates the molecular mechanisms by which mutations in the fukutin gene lead to the phenotype of Fukuyama-type congenital muscular dystrophy (FCMD).
Conclusion
Defective glycosylation of α-dystroglycan caused by fukutin mutations underlies the pathogenesis of muscular dystrophy and brain anomalies in FCMD.
Supporting Evidence
- FCMD is characterized by severe muscle weakness and brain malformations.
- Mutations in the fukutin gene lead to defective glycosylation of α-dystroglycan.
- Defective glycosylation disrupts the linkage between α-dystroglycan and laminin.
Takeaway
Fukuyama-type congenital muscular dystrophy is a serious condition caused by a gene mutation that affects muscle and brain development, leading to weakness and other problems.
Methodology
The review summarizes clinical features, genetic mutations, and molecular mechanisms related to FCMD.
Participant Demographics
The incidence of FCMD is particularly high in the Japanese population.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website